Novel multimetric MRI detects improved future liver remnant quality post-dual vein embolization

Hepatica showed a significant improvement in future liver remnant (FLR) health, measured by cT1 and PDFF, in 10 consecutive patients with liver metastasis and insufficient FLR after undergoing dual vein embolization in the Precision1 clinical trial. “This is a significant advance in our understanding of how to prevent liver failure in patients undergoing major liver surgery.”